Lunai Bioworks Inc. (Nasdaq: LNAI) has completed a 10-for-1 reverse stock split, reducing its outstanding shares from approximately 231.8 million to 23.2 million. The move is aimed at enhancing capital efficiency and meeting Nasdaq's minimum bid price requirements, following the company's recent rebranding and strategic focus on AI-powered therapeutics and biodefense.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lunai Bioworks Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1079907) on September 30, 2025, and is solely responsible for the information contained therein.
Comments